市场调查报告书
商品编码
1616697
β-葡聚醣市场机会、成长动力、产业趋势分析与 2024-2032 年预测Beta Glucan Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024-2032 |
2023年,全球β-葡聚醣市场价值为4.216亿美元,预计2024年至2032年复合年增长率为7.2%。需求健康和保健产品的需求正在激增,有可能推动市场成长。例如,美国疾病管制与预防中心强调,在美国,心臟病每年导致近647,000 人死亡。 ,进一步增强免疫力。萃取和配方方面的技术进步也在这一市场扩张中发挥关键作用。此外,电子商务平台的崛起正在扩大消费者获得β-葡聚醣产品的机会。
主要参与者不仅在创新,而且在建立策略伙伴关係以抓住新兴机会。然而,β-葡聚醣市场的成长轨迹可能会受到监管挑战和研发所需的大量投资的阻碍。技术进步正在推动全球 β-葡聚醣产业的显着成长和创新。值得注意的趋势包括新型萃取方法的出现,包括酵素法和发酵技术。
这些方法不仅提高了产量和纯度,而且还降低了成本。此外,奈米技术的突破正在增强β-葡聚醣的生物利用度和功效,特别是在功能性食品和药品中。整个行业根据提取物和地区进行划分。依产品划分,市场分为谷物萃取、酵母、蘑菇和海藻。
市场范围 | |
---|---|
开始年份 | 2023年 |
预测年份 | 2024-2032 |
起始值 | 4.216 亿美元 |
预测值 | 7.778 亿美元 |
复合年增长率 | 7.2% |
谷物进一步细分为燕麦和大麦。到 2032 年,谷物谷物领域将实现 2.789 亿美元的收入,复合年增长率为 6.9%。预计这将推动未来几年对谷物的需求。每日仅消耗 3 克燕麦 β-葡聚醣即可使 LDL 胆固醇降低 10%,心血管疾病风险降低 20%。
北美β-葡聚醣市场预计将达到2.553亿美元,2024年至2032年复合年增长率为7%。值得注意的趋势包括复杂的萃取和纯化技术的发展,这些技术提高了 β-葡聚醣的品质和生物利用度。酶水解和先进过滤等技术正在简化 β-葡聚醣的生产,以产生卓越的纯度和效力。此外,生物技术正在率先开发具有客製化特性的 β-葡聚醣,以实现特定的健康益处,例如增强免疫支持和增强肠道健康。
The Global Beta Glucan Market was valued at USD 421.6 million in 2023 and is projected to grow at a CAGR of 7.2% from 2024 to 2032. As chronic health issues like diabetes, high cholesterol, heart disease, and obesity become more prevalent, the demand for health and wellness products is surging, potentially fueling market growth. For instance, the Centers for Disease Control and Prevention highlights that heart diseases lead to nearly 647,000 annual deaths in the U.S. Beta-glucan, an indigestible fiber, not only slows digestion to help regulate blood sugar levels but also boosts the immune system, further enhancing its market appeal. Technological advancements in extraction and formulation are also playing a pivotal role in this market expansion. Moreover, the ascent of e-commerce platforms is broadening consumer access to beta-glucan products.
Key players are not only innovating but also forging strategic partnerships to seize emerging opportunities. Nevertheless, the beta-glucan market's growth trajectory could be impeded by regulatory challenges and the significant investments required for research and development. Technological advancements are propelling significant growth and innovation in the global beta-glucan industry. Noteworthy trends encompass the emergence of novel extraction methods, including enzymatic and fermentation-based techniques.
These methods not only boost yield and purity but also curtail costs. Additionally, breakthroughs in nanotechnology are amplifying the bioavailability and efficacy of beta-glucans, particularly in functional foods and pharmaceuticals. The overall industry is divided based on extract and region. By products, the market is segmented into extracting cereal grains, yeast, mushroom, and seaweed.
Market Scope | |
---|---|
Start Year | 2023 |
Forecast Year | 2024-2032 |
Start Value | $421.6 Million |
Forecast Value | $777.8 Million |
CAGR | 7.2% |
Cereal grains are further subdivided into oats and barley. The cereal grains segment will capture USD 278.9 million and demonstrate a 6.9% CAGR through 2032. Oats are known for their ability to lower blood cholesterol and sugar levels, as well as prevent cardiovascular issues. This is projected to drive the demand for cereal grains in the coming years. Daily consumption of just 3 grams of oat beta-glucan can lead to a 10% reduction in LDL cholesterol and a 20% decrease in the risk of cardiovascular disease.
North America beta glucan market is projected to achieve USD 255.3 million, with a CAGR of 7% from 2024 to 2032. Technological advancements are reshaping the market in North America. Noteworthy trends encompass the evolution of sophisticated extraction and purification technologies, which bolster the quality and bioavailability of beta-glucans. Techniques like enzymatic hydrolysis and advanced filtration are streamlining beta-glucan production to yield superior purity and potency. Furthermore, biotechnology is pioneering the development of beta-glucans with customized properties, targeting specific health benefits, such as boosted immune support and enhanced gut health.